1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018, 68:394-424.
2. Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Pineros M, Znaor A, Bray F: Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 2019, 144:1941-1953.
3. Attar E, Dey S, Hablas A, Seifeldin IA, Ramadan M, Rozek LS, Soliman AS: Head and neck cancer in a developing country: A population-based perspective across 8years. Oral Oncology 2010, 46:591-596.
4. Nandakumar A: Survival in head and neck cancers-results of a multi-institution study. Asian Pacific Journal of Cancer Prevention 2016, 17:1745-1754.
5. Pai SI, Westra WH: Molecular Pathology of Head and Neck Cancer: Implications for Diagnosis, Prognosis, and Treatment. Annual Review of Pathology: Mechanisms of Disease 2009, 4:49-70.
6. Farsi NJ, Rousseau M-C, Schlecht N, Castonguay G, Allison P, Nguyen-Tan PF, Soulières D, Coutlée F, Hier M, Madathil S: Aetiological heterogeneity of head and neck squamous cell carcinomas: the role of human papillomavirus infections, smoking and alcohol. Carcinogenesis 2017, 38:1188-1195.
7. Blot WJ, McLaughlin JK, Winn DM, Austin DF, Greenberg RS, Preston-Martin S, Bernstein L, Schoenberg JB, Stemhagen A, Fraumeni JF: Smoking and drinking in relation to oral and pharyngeal cancer. Cancer research 1988, 48:3282-3287.
8. Hashibe M, Brennan P, Chuang S-C, Boccia S, Castellsague X, Chen C, Curado MP, Dal Maso L, Daudt AW, Fabianova E, et al: Interaction between Tobacco and Alcohol Use and the Risk of Head and Neck Cancer: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiology Biomarkers & Prevention 2009, 18:541-550.
9. Koh A, Bäckhed F: From association to causality: the role of the gut microbiota and its functional products on host metabolism. Molecular cell 2020, 78:584-596.
10. Helmink BA, Khan MW, Hermann A, Gopalakrishnan V, Wargo JA: The microbiome, cancer, and cancer therapy. Nature medicine 2019, 25:377-388.
11. Czesnikiewicz-Guzik M, Müller DN: Scientists on the spot: salt, the microbiome, and cardiovascular diseases. Cardiovascular research 2018, 114:e72-e73.
12. Hansen JJ, Sartor RB: Therapeutic manipulation of the microbiome in IBD: current results and future approaches. Current treatment options in gastroenterology 2015, 13:105-120.
13. Kim D, Zeng MY, Núñez G: The interplay between host immune cells and gut microbiota in chronic inflammatory diseases. Experimental & molecular medicine 2017, 49:e339-e339.
14. Salihoğlu R, Önal-Süzek T: Tissue Microbiome Associated With Human Diseases by Whole Transcriptome Sequencing and 16S Metagenomics. Frontiers in Genetics 2021, 12:281.
15. Papotto PH, Yilmaz B, Silva-Santos B: Crosstalk between γδ T cells and the microbiota. Nature Microbiology 2021:1-8.
16. Ley RE, Turnbaugh PJ, Klein S, Gordon JI: Human gut microbes associated with obesity. nature 2006, 444:1022-1023.
17. Routy B, Le Chatelier E, Derosa L, Duong CP, Alou MT, Daillère R, Fluckiger A, Messaoudene M, Rauber C, Roberti MP: Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors. Science 2018, 359:91-97.
18. Matson V, Fessler J, Bao R, Chongsuwat T, Zha Y, Alegre M-L, Luke JJ, Gajewski TF: The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients. Science 2018, 359:104-108.
19. Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews M, Karpinets T, Prieto P, Vicente D, Hoffman K, Wei S: Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients. Science 2018, 359:97-103.
20. Ferreira RM, Pereira-Marques J, Pinto-Ribeiro I, Costa JL, Carneiro F, Machado JC, Figueiredo C: Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota. Gut 2018, 67:226-236.
21. Pushalkar S, Hundeyin M, Daley D, Zambirinis CP, Kurz E, Mishra A, Mohan N, Aykut B, Usyk M, Torres LE: The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression. Cancer discovery 2018, 8:403-416.
22. Sfanos KS, Sauvageot J, Fedor HL, Dick JD, De Marzo AM, Isaacs WB: A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms. The Prostate 2008, 68:306-320.
23. Urbaniak C, Gloor GB, Brackstone M, Scott L, Tangney M, Reid G: The microbiota of breast tissue and its association with breast cancer. Applied and environmental microbiology 2016, 82:5039-5048.
24. Lehouritis P, Cummins J, Stanton M, Murphy CT, McCarthy FO, Reid G, Urbaniak C, Byrne WL, Tangney M: Local bacteria affect the efficacy of chemotherapeutic drugs. Scientific reports 2015, 5:1-12.
25. Panebianco C, Andriulli A, Pazienza V: Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies. Microbiome 2018, 6:1-13.
26. Yu T, Guo F, Yu Y, Sun T, Ma D, Han J, Qian Y, Kryczek I, Sun D, Nagarsheth N: Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell 2017, 170:548-563. e516.
27. Irfan M, Delgado RZR, Frias-Lopez J: The oral microbiome and cancer. Frontiers in immunology 2020, 11.
28. Gallimidi AB, Fischman S, Revach B, Bulvik R, Maliutina A, Rubinstein AM, Nussbaum G, Elkin M: Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model. Oncotarget 2015, 6:22613.
29. Hajishengallis G: Immunomicrobial pathogenesis of periodontitis: keystones, pathobionts, and host response. Trends in immunology 2014, 35:3-11.
30. Hajishengallis G: Periodontitis: from microbial immune subversion to systemic inflammation. Nature Reviews Immunology 2015, 15:30-44.
31. Galvão-Moreira LV, da Cruz MCFN: Oral microbiome, periodontitis and risk of head and neck cancer. Oral oncology 2016, 53:17-19.
32. Karmakar S, Kar A, Thakur S, Rao VU: Periodontitis and oral Cancer-A striking link. Oral oncology 2020, 106:104630.
33. Fitzpatrick SG, Katz J: The association between periodontal disease and cancer: a review of the literature. Journal of dentistry 2010, 38:83-95.
34. Javed F, Warnakulasuriya S: Is there a relationship between periodontal disease and oral cancer? A systematic review of currently available evidence. Critical reviews in oncology/hematology 2016, 97:197-205.
35. Poore GD, Kopylova E, Zhu Q, Carpenter C, Fraraccio S, Wandro S, Kosciolek T, Janssen S, Metcalf J, Song SJ, et al: Microbiome analyses of blood and tissues suggest cancer diagnostic approach. Nature 2020, 579:567-574.
36. Deng M, Brägelmann J, Kryukov I, Saraiva-Agostinho N, Perner S: FirebrowseR: an R client to the Broad Institute’s Firehose Pipeline. Database 2017, 2017:baw160.
37. Team RC: R: A language and environment for statistical computing. 2013.
38. Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, Huttenhower C: Metagenomic biomarker discovery and explanation. Genome Biol 2011, 12:R60.
39. Langille MGI, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA, Clemente JC, Burkepile DE, Vega Thurber RL, Knight R, et al: Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nature Biotechnology 2013, 31:814-821.
40. Fernandes AD, Reid JN, Macklaim JM, McMurrough TA, Edgell DR, Gloor GB: Unifying the analysis of high-throughput sequencing datasets: characterizing RNA-seq, 16S rRNA gene sequencing and selective growth experiments by compositional data analysis. Microbiome 2014, 2:15.
41. Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork P: STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic acids research 2019, 47:D607-D613.
42. Doncheva NT, Morris JH, Gorodkin J, Jensen LJ: Cytoscape StringApp: Network Analysis and Visualization of Proteomics Data. Journal of Proteome Research 2019, 18:623-632.
43. Chin CH, Chen SH, Wu HH, Ho CW, Ko MT, Lin CY: cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol 2014, 8 Suppl 4:S11.
44. Jiao X, Sherman BT, Huang DW, Stephens R, Baseler MW, Lane HC, Lempicki RA: DAVID-WS: a stateful web service to facilitate gene/protein list analysis. Bioinformatics 2012, 28:1805-1806.
45. Yu G, Wang L-G, Han Y, He Q-Y: clusterProfiler: an R package for comparing biological themes among gene clusters. Omics: a journal of integrative biology 2012, 16:284-287.
46. Banerjee S, Tian T, Wei Z, Shih N, Feldman MD, Alwine JC, Coukos G, Robertson ES: The ovarian cancer oncobiome. Oncotarget 2017, 8:36225.
47. Mao Q, Jiang F, Yin R, Wang J, Xia W, Dong G, Ma W, Yang Y, Xu L, Hu J: Interplay between the lung microbiome and lung cancer. Cancer letters 2018, 415:40-48.
48. Aviles-Jimenez F, Guitron A, Segura-Lopez F, Mendez-Tenorio A, Iwai S, Hernandez-Guerrero A, Torres J: Microbiota studies in the bile duct strongly suggest a role for Helicobacter pylori in extrahepatic cholangiocarcinoma. Clinical Microbiology and Infection 2016, 22:178. e111-178. e122.
49. Nakatsu G, Li X, Zhou H, Sheng J, Wong SH, Wu WKK, Ng SC, Tsoi H, Dong Y, Zhang N, et al: Gut mucosal microbiome across stages of colorectal carcinogenesis. Nature Communications 2015, 6:8727.
50. Lu Y, Chen J, Zheng J, Hu G, Wang J, Huang C, Lou L, Wang X, Zeng Y: Mucosal adherent bacterial dysbiosis in patients with colorectal adenomas. Scientific Reports 2016, 6:26337.
51. Mangerich A, Knutson CG, Parry NM, Muthupalani S, Ye W, Prestwich E, Cui L, McFaline JL, Mobley M, Ge Z: Infection-induced colitis in mice causes dynamic and tissue-specific changes in stress response and DNA damage leading to colon cancer. Proceedings of the National Academy of Sciences 2012, 109:E1820-E1829.
52. Wu S, Rhee K-J, Albesiano E, Rabizadeh S, Wu X, Yen H-R, Huso DL, Brancati FL, Wick E, McAllister F: A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nature medicine 2009, 15:1016-1022.
53. Boleij A, Hechenbleikner EM, Goodwin AC, Badani R, Stein EM, Lazarev MG, Ellis B, Carroll KC, Albesiano E, Wick EC: The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients. Clinical Infectious Diseases 2015, 60:208-215.
54. Gur C, Ibrahim Y, Isaacson B, Yamin R, Abed J, Gamliel M, Enk J, Bar-On Y, Stanietsky-Kaynan N, Coppenhagen-Glazer S: Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity 2015, 42:344-355.
55. Arthur JC, Perez-Chanona E, Mühlbauer M, Tomkovich S, Uronis JM, Fan T-J, Campbell BJ, Abujamel T, Dogan B, Rogers AB: Intestinal inflammation targets cancer-inducing activity of the microbiota. science 2012, 338:120-123.
56. Iida N, Dzutsev A, Stewart CA, Smith L, Bouladoux N, Weingarten RA, Molina DA, Salcedo R, Back T, Cramer S: Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science 2013, 342:967-970.
57. Orberg ET, Fan H, Tam AJ, Dejea CM, Shields CD, Wu S, Chung L, Finard BB, Wu X, Fathi P: The myeloid immune signature of enterotoxigenic Bacteroides fragilis-induced murine colon tumorigenesis. Mucosal immunology 2017, 10:421-433.
58. Arthur JC, Gharaibeh RZ, Uronis JM, Perez-Chanona E, Sha W, Tomkovich S, Mühlbauer M, Fodor AA, Jobin C: VSL# 3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer. Scientific reports 2013, 3:1-9.
59. Derosa L, Hellmann M, Spaziano M, Halpenny D, Fidelle M, Rizvi H, Long N, Plodkowski A, Arbour K, Chaft J: Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer. Annals of Oncology 2018, 29:1437-1444.
60. Pflug N, Kluth S, Vehreschild JJ, Bahlo J, Tacke D, Biehl L, Eichhorst B, Fischer K, Cramer P, Fink A-M: Efficacy of antineoplastic treatment is associated with the use of antibiotics that modulate intestinal microbiota. Oncoimmunology 2016, 5:e1150399.
61. Jacobsohn DA, Vogelsang GB: Acute graft versus host disease. Orphanet journal of rare diseases 2007, 2:1-9.